Optimum treatment algorithm in management of advanced prostate cancer

Working to improve global cancer care access in low middle-income countries

Update on the latest in PARP inhibitors for prostate cancer

ASCO Direct Highlights 2022: prostate cancer highlights

ASCO Direct Highlights 2022: lung cancer highlights

Locally and advanced immunotherapy developments and new agents in lung cancer

Axicabtagene ciloleucel provides superior EFS vs standard of care in elderly with relapsed/refractory large B-cell lymphoma

Using combined oral contraceptives may decrease risk of Ovarian, Endometrial and Colorectal cancer

War in Ukraine: Global cancer aid to support refugees

War in Ukraine: The International Brain Tumour Alliance's response to aiding refugees during the crisis

Rucaparib effective as maintenance therapy following first-line platinum-based chemo in ovarian cancer

RAGNAR study evidences efficacy and safety of erdafitinib in patients with advanced FGFR+ malignancies